Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Wave Life Sciences Ltd. (WVE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 10,161,399 | 0.86 | Add 9.50% | 0.07 | $7.25 | $73,670,143 | SEC |
| 2025 Q4 | 9,280,237 | 1.69 | Add 10.59% | 0.16 | $17.00 | $157,764,029 | SEC |
| 2025 Q3 | 8,391,856 | 0.82 | Add 1.58% | 0.01 | $7.32 | $61,428,386 | SEC |
| 2025 Q2 | 8,261,683 | 0.82 | $6.50 | $53,700,940 | SEC | ||
| 2025 Q1 | 8,261,683 | 1.20 | Add 0.01% | <0.01 | $8.08 | $66,754,399 | SEC |
| 2024 Q4 | 8,261,242 | 1.84 | Reduce 17.78% | 0.29 | $12.37 | $102,191,564 | SEC |
| 2024 Q3 | 10,047,520 | 1.61 | Add 31.01% | 0.38 | $8.20 | $82,389,664 | SEC |
| 2024 Q2 | 7,669,361 | 0.73 | Reduce 0.24% | <0.01 | $4.99 | $38,270,111 | SEC |
| 2024 Q1 | 7,688,079 | 0.88 | Reduce 8.99% | 0.08 | $6.17 | $47,435,447 | SEC |
| 2023 Q4 | 8,447,804 | 0.85 | Add 28.11% | 0.19 | $5.05 | $42,661,410 | SEC |
| 2023 Q3 | 6,594,319 | 0.85 | Reduce 0.04% | <0.01 | $5.75 | $37,917,334 | SEC |
| 2023 Q2 | 6,596,778 | 0.51 | $3.64 | $24,012,272 | SEC | ||
| 2023 Q1 | 6,596,778 | 0.72 | Reduce 7.06% | 0.08 | $4.33 | $28,564,049 | SEC |
| 2022 Q4 | 7,097,664 | 1.17 | Reduce 9.07% | 0.06 | $7.00 | $49,683,648 | SEC |
| 2022 Q3 | 7,805,219 | 0.64 | $3.61 | $28,177,000 | SEC | ||
| 2022 Q2 | 7,805,219 | 0.63 | Add 39.54% | 0.18 | $3.25 | $25,367,000 | SEC |
| 2022 Q1 | 5,593,389 | 0.20 | $2.00 | $11,187,000 | SEC | ||
| 2021 Q4 | 5,593,389 | 0.20 | Add 75.16% | 0.09 | $3.14 | $17,563,000 | SEC |
| 2021 Q3 | 3,193,389 | 0.16 | Add 3.41% | <0.01 | $4.90 | $15,648,000 | SEC |
| 2021 Q2 | 3,088,131 | 0.20 | Add 0.16% | <0.01 | $6.66 | $20,567,000 | SEC |
| 2021 Q1 | 3,083,201 | 0.16 | Buy | 0.16 | $5.61 | $17,297,000 | SEC |